Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection

Since emerging in 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been a global public health threat with a high fatality rate and worldwide distribution. There are no approved vaccines or therapies for MERS until now. Passive immunotherapy with neutralizing monoclonal antibodies (...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Hui-Ju, Liu, Jian-Wei, Yu, Hao, Yu, Xue-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315345/
https://www.ncbi.nlm.nih.gov/pubmed/30513619
http://dx.doi.org/10.3390/v10120680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315345/
https://www.ncbi.nlm.nih.gov/pubmed/30513619
http://dx.doi.org/10.3390/v10120680

Ejemplares similares